Literature DB >> 20645880

The marketing of dietary supplements in North America: the emperor is (almost) naked.

Norman J Temple1.   

Abstract

BACKGROUND: Many different dietary supplements are being sold in North America. The quality of the evidence supporting their efficacy covers a wide spectrum: Some are based on solid science (such as vitamin D and fish oil), whereas with most supplements there is little or no supporting evidence. Types of supplements commonly sold include exotic fruit juices (such as goji juice) and single herbs or mixture of herbs. Common claims made in support of particular supplements are that they are rich in antioxidants, induce detoxification, stimulate the immune system, and cause weight loss. Supplements are commonly sold through health food stores and by multilevel marketing. Sales may be promoted using bulk mail ("junk mail"), spam e-mails, and Web sites. A large part of marketing is based on claims that are blatantly dishonest.
CONCLUSIONS: Whereas supplements for which good supporting evidence exists generally cost around $3-$4 per month, those that are heavily promoted for which there is little supporting evidence cost about $20-$60 per month. The major cause of this problem in the United States is weakness of the law. There is an urgent need for stricter regulation and for giving better advice to the general public.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645880     DOI: 10.1089/acm.2009.0176

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  2 in total

1.  Missing the emperor altogether: a call for research on how consumers use dietary supplements.

Authors:  Jennifer Jo Thompson; Mark Nichter
Journal:  J Altern Complement Med       Date:  2011-03-23       Impact factor: 2.579

2.  Americans' use of dietary supplements that are potentially harmful in CKD.

Authors:  Vanessa Grubbs; Laura C Plantinga; Delphine S Tuot; Elizabeth Hedgeman; Rajiv Saran; Sharon Saydah; Deborah Rolka; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2013-02-14       Impact factor: 8.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.